NCCN Launches Health Equity Report Card to Address Racial Disparities in Cancer Care
“The National Comprehensive Cancer Network has partnered with the American Cancer Society Cancer Action Network and the National Minority Quality Forum to launch the new Health Equity Report Card pilot program to address structural and interpersonal bigotry that results in disparities in cancer care and outcomes.”
Removing less during surgery for early lung cancer may be better
”Some patients having surgery for early-stage lung cancer may no longer need to lose an entire lobe of their lung, new research shows.”
Lung cancer screening based on risk may reduce costs
February 10, 2023 – “CT lung cancer screening of people based on their personal risk may be more cost-effective than the current strategy recommended by the U.S. Preventive Services Task Force (USPSTF), according to a study published February 6 in Annals of Internal Medicine.”
“What apparently was just a cough turned into a stage 3 Lung cancer diagnosis”: 26 year old shares how she dealt with cancer
“For Rasika Bombatkar, sharing this information with the world was not an easy task. She was diagnosed with stage 3 lung cancer in September 2022. A physiotherapist, the 26 year old, has shared her journey with cancer on several social media platforms.” I had always been big on exercising, sports, and Yoga. I’ve never smoked. My health seemed perfect — this came out of nowhere,” she writes about her health condition which “apparently was just a cough”.”
Key Updates in the Changing NSCLC Treatment Landscape
“In the third interview of this series, Edward B. Garon, MD, reviews the treatment landscape in non–small cell lung cancer, with a focus on immunotherapy and the recent approval of tremelimumab in combination with durvalumab and platinum-based chemotherapy.”
Roswell Park improves accessibility with mobile lung cancer screenings
BUFFALO, N.Y. — “Cancer can take a huge toll on your life, but the earlier it’s detected, the better. That’s why one cancer center is trying to make testing easier, by coming to you. “I’m a smoker for 40 years, and that doesn’t sound good, but I have been and I never had a screening for cancer,” said Francisco Lopez Jr.”
Keytruda Approval Offers ‘Another Form of Insurance’ to Keep Lung Cancer From Returning
“The Food and Drug Administration (FDA) recently approved Keytruda (pembrolizumab) for patients with stage 1B, 2 or 3A non-small cell lung cancer that has been previously treated with surgery and platinum-based chemotherapy, offering this patient population “another form of insurance that they can take to keep their cancer from coming back and spreading,” explained Dr. Roy S. Herbst.”
Reduced breast and lung cancer screening rates in the U.S. during COVID pandemic
“In a recent study published in the journal JAMA Network Open, researchers determined whether the rates for cancer screening tests, such as mammograms for breast cancer and low-dose computed tomography (CT) for lung cancer, decreased during the coronavirus disease 2019 (COVID-19) pandemic.”
Video:
Planning Lung Cancer Screening, Surgery Between Clinicians and Patients
“The armamentarium for lung cancer detection and treatment has become impressive and diverse. Putting these tools to best use, however, take an informed and collaborative strategy between clinicians and patients.”
